Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1984;6:236-241

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Handa, M.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Handa, M.
Right arrow Articles by Saruta, T.

Hypertension, Vol 6, 236-241, Copyright © 1984 by American Heart Association


ARTICLES

Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine

M Handa, K Kondo, H Suzuki and T Saruta

Glucocorticoid hypertension was induced by oral administration of dexamethasone (DX) in male Wistar rats. The mechanism of hypertension was studied by observing the changes in plasma renin activity, urinary excretion of prostaglandin E2 (PGE2), and the pressor response to norepinephrine. Following administration of DX (0.1 mg/day), the blood pressure began to rise within 3 days and reached a plateau on the 5th day (from 108 +/- 2 to 162 +/- 7 mm Hg, mean +/- SE). On the other hand, urine volume and urinary excretion of sodium were increased. In spite of the marked natriuresis and diuresis, the administration of DX resulted in a marked decrease in the urinary excretion of PGE2. This decrease in PGE2 excretion appeared before the blood pressure rose and continued throughout the experiment. Plasma renin activity did not change. The pressor response to norepinephrine was enhanced on the 2nd day of DX treatment, at which time the blood pressure was not yet elevated, and it was further augumented on the 6th day. In the DX- treated rats, the pressor response to norepinephrine was not enhanced by administration of indomethacin, whereas the pressor response was significantly potentiated by indomethacin in control rats. These results suggest that DX-induced hypertension in rats is associated with inhibition of prostaglandin synthesis leading to increased sensitivity in the vascular response to norepinephrine.


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. Baum and O. W. Moe
Glucocorticoid-Mediated Hypertension: Does the Vascular Smooth Muscle Hold All the Answers?
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1251 - 1253.
[Full Text] [PDF]


Home page
J EndocrinolHome page
D. O'Regan, C. J Kenyon, J. R Seckl, and M. C Holmes
Prenatal dexamethasone 'programmes' hypotension, but stress-induced hypertension in adult offspring
J. Endocrinol., February 1, 2008; 196(2): 343 - 352.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. M. Mitchell, A. M. Dorrance, and R. C. Webb
GTP Cyclohydrolase 1 Downregulation Contributes to Glucocorticoid Hypertension in Rats
Hypertension, March 1, 2003; 41(3): 669 - 674.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Sapolsky, L. M. Romero, and A. U. Munck
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions
Endocr. Rev., February 1, 2000; 21(1): 55 - 89.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Hatakeyama, S. Inaba, and I. Miyamori
11ß-Hydroxysteroid Dehydrogenase in Cultured Human Vascular Cells : Possible Role in the Development of Hypertension
Hypertension, May 1, 1999; 33(5): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. E Ullian
The role of corticosteroids in the regulation of vascular tone
Cardiovasc Res, January 1, 1999; 41(1): 55 - 64.
[Full Text] [PDF]


Home page
HypertensionHome page
M. E. Ullian, D. J. Hazen-Martin, L. G. Walsh, R. K. Davda, and B. M. Egan
Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings
Hypertension, June 1, 1996; 27(6): 1346 - 1352.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. E. Ullian and L. G. Walsh
Corticosterone Metabolism and Effects on Angiotensin II Receptors in Vascular Smooth Muscle
Circ. Res., October 1, 1995; 77(4): 702 - 709.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. Murasawa, H. Matsubara, K. Kizima, K. Maruyama, Y. Mori, and M. Inada
Glucocorticoids Regulate V1a Vasopressin Receptor Expression by Increasing mRNA Stability in Vascular Smooth Muscle Cells
Hypertension, October 1, 1995; 26(4): 665 - 669.
[Abstract] [Full Text]